Adjunctive use of interferon γ inducer for treatment of patients with schizophrenia. (Q47964432)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26567593%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

title

Adjunctive use of interferon γ inducer for treatment of patients with schizophrenia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26567593%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

Olga Anatolyevna Lobacheva

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26567593%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Arkady V. Semke

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26567593%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Tamara Parfenovna Vetlugina

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26567593%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Svetlana Alexandrovna Sergeeva

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26567593%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Valentina Borisovna Nikitina

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26567593%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Tatiana Ivanovna Nevidimova

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26567593%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

publication date

16 November 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26567593%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

published in

Acta Neuropsychiatrica

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26567593%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26567593%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26567593%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

149-156

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26567593%20AND%20SRC:MED&resulttype=core&format=json

Cytokine hypothesis of schizophrenia pathogenesis: evidence from human studies and animal models

29 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2015.60

A model for homeopathic remedy effects: low dose nanoparticles, allostatic cross-adaptation, and time-dependent sensitization in a complex adaptive system

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2015.60

Schizophrenia, autoimmunity and immune system dysregulation: a comprehensive model updated and revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2015.60

The Effect of Long-Term Antipsychotic Treatment on Prolactin

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2015.60

Tardive dyskinesia in relation to estimated dopamine D2 receptor occupancy in patients with schizophrenia: analysis of the CATIE data

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2015.60

Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 1: pathophysiology and mechanisms of induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2015.60

Differentiation of effector CD4 T cell populations (*)

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2015.60

Acute schizophrenia is accompanied by reduced T cell and increased B cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2015.60

Th1, Th2 and Th3 cytokine alteration in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2015.60

Neuropsychiatric disorders related to interferon and interleukins treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2015.60

Activity of ultra-low doses of antibodies to gamma-interferon against lethal influenza A(H1N1)2009 virus infection in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2015.60

Application of ultralow doses of antibodies to interferon-gamma in complex therapy of bacterial infections and prophylaxis of bacterial complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2015.60

Altered IL-2, IL-6 and IL-8 serum levels in schizophrenia patients with tardive dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2015.60

Major depressive disorder with psychotic features induced by interferon-alpha treatment for hepatitis C in a polydrug abuser

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2015.60

7 January 2021

Monocytic, Th1 and th2 cytokine alterations in the pathophysiology of schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2015.60

7 January 2021

The use of anaferon (pediatric formulation) for prophylaxis of acute respiratory viral infections in preschool children

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2015.60

7 January 2021

Neuroleptic-induced deficit syndrome: old problem, new challenge

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2015.60

7 January 2021

Acute Delirium, Delusion, and Depression During IFN-β-1a Therapy for Multiple Sclerosis: A Case Report

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2015.60

7 January 2021

The immune system and schizophrenia. An integrative view.

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2015.60

7 January 2021

Impaired monocyte activation in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2015.60

7 January 2021

Comparative efficiency of Proproten-100 during the therapy of patients with alcoholism in the stage of therapeutic remission

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2015.60

7 January 2021

Dysregulation of chemo-cytokine production in schizophrenic patients versus healthy controls

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2015.60

7 January 2021

Identifiers

DOI

10.1017/NEU.2015.60

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26567593%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference